Clinical Trials in Cleveland

Showing 11841-11860 of 16,969 trials

Multiple Ascending Dose Study of PRX003 in Subjects With Psoriasis

NCT02630901

This multiple ascending dose study is to determine safety, tolerability, pharmacokinetics and immunogenicity of PRX003 in approximately 56 patients with Psoriasis.

Psoriasis

Prothena Biosciences Limited48 participantsStarted Mar 2016

San Diego, California, United States • Coral Gables, Florida, United States • Ocala, Florida, United States +6 more locations

COMPLETEDPhase 4< 1 mile

Does Treximet Improve Productivity and Patient Satisfaction Due to Sustained Response and Consistency of Response?

NCT01086358

Researchers want to learn about work productivity after treatment of a migraine headache with your usual migraine medication as compared to your work productivity after treatment with Treximet. During this research subjects will take Treximet to treat 3 workday migraine attacks. For a second part of the research subjects will take their usual prescribed medication for 3 workday migraine attacks. The subjects will complete questionnaires after treating each migraine.

Workplace Migraine Treatment

The Cleveland Clinic60 participantsStarted Sep 2009

Cleveland, Ohio, United States

COMPLETEDNA< 1 mile

Utilizing the Arts to Improve Health, Resilience, and Well-Being Among Cancer Patients and Their Caregivers

NCT03272880

The purpose of this study is to evaluate the impact of arts-based programming on health, well-being, and resilience. Patients who have cancer or are the caregivers of someone with cancer are being asked to take part in this study.

Cancer

Case Comprehensive Cancer Center6 participantsStarted Sep 2017

Cleveland, Ohio, United States

Multiple Ascending Dose Study of PRX003 in Subjects With Psoriasis

Does Treximet Improve Productivity and Patient Satisfaction Due to Sustained Response and Consistency of Response?

Utilizing the Arts to Improve Health, Resilience, and Well-Being Among Cancer Patients and Their Caregivers

Find Trials by Condition in Cleveland

MEDTRONIC ADAPTA, VERSA AND SENSIA nEw3 POST APPROVAL STUDY

Bevacizumab and Temozolomide or Bevacizumab and Paclitaxel Albumin-Stabilized Nanoparticle Formulation and Carboplatin in Treating Patients With Stage IV Malignant Melanoma That Cannot Be Removed by Surgery

Dose-Ranging Study to Evaluate the Glycemic Effects, Safety, and Tolerability of Metformin Delayed Release in Subjects With T2DM

Safety and Efficacy of Cariprazine as an Adjunctive to Antidepressant Therapy in Major Depressive Disorder

REVEAL AF: Incidence of AF in High Risk Patients

LINX Reflux Management System Clinical Study Protocol

A Gilead Sequence Registry of Subjects Who Did Not Achieve Sustained Virologic Response

Lamotrigine in Treating Peripheral Neuropathy Caused by Chemotherapy in Patients With Cancer

Efficacy and Safety of Alirocumab Versus Usual Care on Top of Maximally Tolerated Statin Therapy in Patients With Type 2 Diabetes and Mixed Dyslipidemia (ODYSSEY DM-Dyslipidemia)

A Study to Compare a New Long-Acting Insulin (LY2605541) and Human Insulin NPH in Participants With Type 2 Diabetes

Telescope Exchange Study

Evaluation of Tabalumab Using Auto-Injector or Prefilled Syringe in Participants With Rheumatoid Arthritis (RA)

The Effect Of NS-0200 Versus Placebo On Hepatic Fat Content In Patients With Non Alcoholic Fatty Liver Disease

Sofosbuvir-Containing Regimens Without Interferon For Treatment of Acute Hepatitis C Virus (HCV) Infection

Eating Disorders Programs: An Indicated Trial

Study Of Palbociclib (PD-0332991) In Renal Impairment

Study to Evaluate GSK Biologicals' Herpes Zoster Vaccine GSK1437173A in Human Immunodeficiency Virus (HIV)-Infected Subjects